Apogee Therapeutics, Inc. (APGE)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 02:54PM EDT. Market open.
| Previous close | 44.31 |
| Open | 44.14 |
| Bid | 42.51 x 100 |
| Ask | 42.86 x 100 |
| Day's range | 42.17 - 45.04 |
| 52-week range | 14.19 - 72.29 |
| Volume | |
| Avg. volume | 523,819 |
| Market cap | 2.4B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Here's Why We're Not Too Worried About Apogee Therapeutics' (NASDAQ:APGE) Cash Burn Situation
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
- Simply Wall St.
With 54% institutional ownership, Apogee Therapeutics, Inc. (NASDAQ:APGE) is a favorite amongst the big guns
Key Insights Institutions' substantial holdings in Apogee Therapeutics implies that they have significant influence...
- Zacks
Apogee (APGE) Stock Rallies 95.6% in a Month: Here's Why
Apogee (APGE) surges 95.6% in a month after reporting positive interim results from its phase I study for APG777 to treat AD. The company plans to initiate a phase II study for the same indication.
© 2024 Yahoo. All rights reserved.